Legal & General Group PLC Biomarin Pharmaceutical Inc Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Legal & General Group PLC holds 1,471,049 shares of BMRN stock, worth $98 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,471,049
Previous 1,471,049 -0.0%
Holding current value
$98 Million
Previous $103 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $3.3 Million - $4.49 Million
-47,852 Reduced 3.15%
1,471,049 $103 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $10.5 Million - $13 Million
140,789 Added 10.22%
1,518,901 $125 Million
Q1 2024

May 14, 2024
SELL
$83.81 - $99.0 $1.04 Million - $1.23 Million
-12,414 Reduced 0.89%
1,378,112 $120 Million
Q4 2023

Feb 15, 2024
BUY
$76.22 - $98.51 $13.3 Million - $17.1 Million
173,874 Added 14.29%
1,390,526 $134 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $133,644 - $148,428
-1,571 Reduced 0.13%
1,216,652 $108 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $4.46 Million - $5.16 Million
51,426 Added 4.41%
1,218,223 $106 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $124,415 - $166,288
-1,418 Reduced 0.12%
1,166,797 $113 Million
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $5.16 Million - $6.93 Million
-63,752 Reduced 5.17%
1,168,215 $121 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $1.55 Million - $1.83 Million
-18,925 Reduced 1.51%
1,231,967 $104 Million
Q2 2022

Aug 22, 2022
BUY
$71.48 - $86.85 $4.77 Million - $5.79 Million
66,683 Added 5.63%
1,250,892 $104 Million
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $7.37 Million - $9.2 Million
99,255 Added 9.15%
1,184,209 $91.3 Million
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $1.14 Million - $1.46 Million
-15,908 Reduced 1.45%
1,084,954 $95.9 Million
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $823,666 - $941,537
-11,016 Reduced 0.99%
1,100,862 $85.1 Million
Q2 2021

Aug 12, 2021
BUY
$75.51 - $84.79 $1.52 Million - $1.7 Million
20,092 Added 1.84%
1,111,878 $92.8 Million
Q1 2021

May 17, 2021
BUY
$74.73 - $90.69 $275,903 - $334,827
3,692 Added 0.34%
1,091,786 $82.4 Million
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $2.77 Million - $3.44 Million
-38,143 Reduced 3.39%
1,088,094 $95.4 Million
Q3 2020

Nov 13, 2020
SELL
$71.87 - $131.03 $384,145 - $700,355
-5,345 Reduced 0.47%
1,126,237 $85.7 Million
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $8.42 Million - $13.1 Million
105,804 Added 10.31%
1,131,582 $140 Million
Q1 2020

May 14, 2020
BUY
$71.37 - $96.85 $2.04 Million - $2.77 Million
28,650 Added 2.87%
1,025,778 $86.7 Million
Q4 2019

Feb 13, 2020
BUY
$64.27 - $86.37 $2.64 Million - $3.54 Million
41,031 Added 4.29%
997,128 $84.3 Million
Q3 2019

Nov 13, 2019
BUY
$67.4 - $85.11 $575,461 - $726,669
8,538 Added 0.9%
956,097 $64.4 Million
Q2 2019

Aug 14, 2019
SELL
$80.35 - $93.9 $581,734 - $679,836
-7,240 Reduced 0.76%
947,559 $81.2 Million
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $17.4 Million - $20.4 Million
207,228 Added 27.72%
954,799 $84.8 Million
Q4 2018

Feb 15, 2019
BUY
$80.14 - $106.07 $4.34 Million - $5.74 Million
54,131 Added 7.81%
747,571 $63.7 Million
Q3 2018

Nov 20, 2018
BUY
$93.92 - $105.72 $386,199 - $434,720
4,112 Added 0.6%
693,440 $67.2 Million
Q2 2018

Aug 10, 2018
SELL
$76.01 - $99.03 $2.4 Million - $3.12 Million
-31,546 Reduced 4.38%
689,328 $64.9 Million
Q1 2018

May 17, 2018
SELL
$77.67 - $92.63 $2.84 Million - $3.39 Million
-36,589 Reduced 4.83%
720,874 $58.4 Million
Q4 2017

Feb 13, 2018
BUY
$80.76 - $95.13 $61.2 Million - $72.1 Million
757,463
757,463 $67.5 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email